Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?

Fundamental and Clinical Pharmacology

Volumn 16, Issue 4, 2002, Pages 273-279

  Gaskari, Seyed Ali ^a   Mani, Ali Reza ^a   Ejtemaei Mehr, Shahram ^a   Namiranian, Khodadad ^a   Homayoun, Houman ^a   Ahmadi, Hossein ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bradycardia; Cholestasis; Isolated atrium; Nitric oxide; Opioid; Rat

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOGUANIDINE; ARGININE; ENDORPHIN; LIVER ENZYME; N(G) NITROARGININE METHYL ESTER; NALTREXONE; NITRIC OXIDE; SODIUM CHLORIDE; TYROSINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BLOOD LEVEL; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CHOLESTASIS; CHRONOTROPISM; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART ATRIUM CONTRACTION; HEART RATE; LIGATION; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ARGININE; BRADYCARDIA; CHOLESTASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; EPINEPHRINE; GUANIDINES; HEART ATRIA; HEART RATE; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

EID: 0036399276     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2002.00089.x     Document Type: Article

References (41)

1. Tajuddin M., Tariq M., Bilgrami N.L., Kumar S. Biochemical and pathological changes in the heart following bile duct ligation. Adv. Myocardiol. (1980) 2 209-212.
2. Song E., Segal I., Hodkinson J., Kew M.C. Sinus bradycardia in obstructive jaundice: correlation with total serum bile acid concentrations. S. Afr. Med. J. (1983) 64 548-551.
3. Binah O., Bomzon A., Blendis L.M., Mordohovich D., Better O.S. Obstructive jaundice blunts myocardial contractile response to isoprenaline in the dog: a clue to the susceptibility of jaundiced patients to shock. Clin. Sci. (1985) 69 647-653.
4. Nahavandi A., Dehpour A.R., Mani A.R., Abdoli A., Homayounfar H., Abdolhoseini M.R. The role of nitric oxide in bradycardia of rats with obstructive cholestasis. Eur. J. Pharmacol. (2001) 411 135-134.
5. Liu H., Ma Z., Lee S.S. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology (2000) 118 937-944.
6. Nahavandi A., Mani A.R., Homayounfar H., Akbari M.R., Dehpour A.R. The role of interaction between endogenous opioids and nitric oxide in pathophysiology of ethanol-induced gastric damage in cholestatic rats. Fundam. Clin. Pharmacol. (2001) 15 181-187.
7. Namiranian K., Samini M., Ejtemaei Mehr S. et al. Mesenteric vascular bed responsiveness in bile duct ligated rats: roles of opioid and nitric oxide systems. Eur. J. Pharmacol. (2001) 423 185-193.
8. Swain M.G., Rothman R.B., Xu H., Vergalla J., Bergasa N.V., Jones E.A. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology (1992) 103 630-635.
9. Dehpour A.R., Rastegar H., Jorjani M., Roushanzamir F., Joharchi K., Ahmadiani A. Subsensitivity to opioids is receptor-specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis. J. Pharmacol. Exp. Ther. (2000) 293 946-951.
10. Jones E.A., Bergasa N.V. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology (1990) 11 884-887.
11. Bergasa N.V., Alling D.W., Talbot T.L., Swain M.G., Turner M.L. Effect of naloxone infusions in patients with the pruritus of cholestasis. Ann. Int. Med. (1995) 123 161-167.
12. Dehpour A.R., Akbarloo N., Ghafourifar P. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis. Behav. Pharmacol. (1998) 9 77-80.
13. Dehpour A.R., Mani A.R., Amanlou M., Nahavandi A., Amanpour S., Bahadori M. Naloxone is protective against indomethacin-induced gastric damage in cholestatic rats. J. Gastroenterol. (1999) 34 178-181.
14. Champion H.C., Kadowitz P.J. A-[Ala2] endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats. Am. J. Physiol. (1998) 274 H1690-H1697.
15. Feldman P.D., Parveen N., Sezen S. Cardiovascular effect of Leuenkephalin in the nucleus tractus solitarius of the rat. Brain Res. (1996) 709 331-336.
16. Kwok E.H., Dun N.J. Endomorphins decrease heart rate and blood pressure possibly by activating vagal afferents in anesthetized rats. Brain Res. (1998) 803 204-207.
17. Devine J.O., Armstead W.M. The role of nitric oxide in opioid-induced pial artery vasodilation. Brain Res. (1995) 675 257-263.
18. Stefano G.B., Hartman A., Bilfinger T.V. et al. Presence of the μ3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J. Biol. Chem. (1995) 270 30290-30293.
19. Han X., Shimoni Y., Giles W.R. An obligatory role for nitric oxide in autonomic control of mammalian heart. J. Physiol. (London) (1994) 479 309-314.
20. 2+ channel current. J. Mol. Cell. Cardiol. (1993) 25 661-666.
21. Cadet P., Bilfinger T.V., Fimiani C., Peter D., Stefano G.B. Human vascular and cardiac endothelia express μ opiate receptor transcript. Endothelium (2000) 7 185-191.
22. James P.C., Goodman D.R., Harbison R.D. Hepatic glutathione and hepatotoxicity: changes induced by selective narcotics. J. Pharmacol. Exp. Ther. (1982) 221 708-714.
23. Tsuji C., Shioya S., Hirota Y. et al. Increased production of nitrotyrosine in lung tissue of rats with radiation-induced acute lung injury. Am. J. Physiol. (2000) 278 L719-L725.
24. Sikuler E., Buchs A.E., Yaari A., Keynan A. Homodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats. Am. J. Physiol. (1991) 260 G161-G166.
25. Herce-Pagliai C., Kotecha S., Shuker D.E.G. Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. Nitric Oxide (1998) 2 324-336.
26. Thornton J.R., Losowsky M.S. Opioid peptides and primary biliary cirrhosis. BMJ (1998) 297 1501-1504.
27. Ghafourifar P., Dehpour A.R., Akbarloo N. Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis. Life Sci. (1997) 60 265-270.
28. Dehpour A.R., Meysami F., Ebrahimi-Daryani N., Akbarloo N. Inhibition by lithium of opioid withdrawal-like syndrome and physical dependency in a model of acute cholestasis in mice. Hum. Psychopharmacol. Clin. Exp. (1998) 13 407-412.
29. Dehpour A.R., Sadeghipour H.R., Nowroozi N., Akbarloo N. The effect of serotonergic system on opioid withdrawal-like syndrom in a mouse model of cholestasis. Hum. Psychopharmacol. Clin. Exp. (2000) 15 423-428.
30. Bergasa N.V., Rothman R.B., Vergalla J., Xu H., Swain M.G., Jones E.A. Central μ-opioid receptors are down-regulated in rat model of cholestasis. J. Hepatol. (1992) 15 220-225.
31. Bergasa N.V., Alling D.W., Vergalla J., Xu H., Swain M.G., Jones E.A. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J. Hepatol. (1994) 20 85-90.
32. Swain M.G., Vergalla J., Bergasa N.V., Jones E.A. Sympathetic nerves, but not the adrenal gland, contribute to elevated plasma levels of met-enkephalin in rats with acute cholestatic hepatitis. Regul. Pept. (1993) 46 535-542.
33. Swain M.G., MacArthur L., Vergalla J., Jones E.A. Adrenal secretion of BAM-22p, a potent opioid peptide is enhanced in rats with acute cholestasis. Am. J. Physiol. (1994) 266 G201-G205.
34. Chan R., Irvin R., White J. Cardiovascular changes during morphine administration and spontaneous withdrawal in the rat. Eur. J. Pharmacol. (1999) 368 25-33.
35. Mani A.R., Nahavandi A., Moosavi M., Safarinejad R., Dehpour A.R. Dual nitric oxide mechanisms of choleostasis-induced brady cardid in the rat. Clin. Exp. Physiol. Pharmacol. (2002) 29 (in press).
36. Ferraz J.G.P., Wallace J.L. Underlying mechanisms of portal hypertensive gastropathy. J. Clin. Gastroenterol. (1997) 25 S73-S78.
37. Ottesen L.H., Harry D., Frost M. et al. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic. Biol. Med. (2001) 31 790-798.
38. Nieto-Fernandez F.E., Mattocks D., Cavani F., Salzet M., Stefano G.B. Morphine coupling to invertebrate immunocyte nitric oxide release is dependent on intracellular calcium transits. Comp. Biochem. Physiol. (1999) 123 295-299.
39. Muriel P., Gonzalez P. Liver damage induced by acute cholestasis in the rat is ameliorated partially by l-arginine. Comp. Biochem. Physiol. (1998) 120 421-424.
40. Mani A.R., Nahavandi A., Mani A.H., Dehpour A.R. Role of nitric oxide in hypodipsia of rats with obstructive jaundice. J. Pharm. Pharmacol. (2001) 53 277-281.
41. Chen J.S., Ker C.G., Lee K.T., Sheen P.C. Changes of insulin and somatostain and their relationship to liver regeneration in experimental obstructive jaundice. Kaohsiung. J. Med. Sci. (1997) 13 653-660.